These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 32379941)

  • 1. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.
    Zhang Y; Zhong Q; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
    Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
    Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.
    Ma L; Wen Y; Li Z; Wu N; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():929924. PubMed ID: 35898469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
    Gao J; Fan YZ; Gao SS; Zhang WT
    Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
    Wu N; Sun H; Sun Q; Zhang F; Ma L; Hu Y; Cong X
    BMC Cancer; 2023 May; 23(1):414. PubMed ID: 37158840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
    Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
    J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta analysis of the diagnostic value of circulating miRNA in benign and malignant pulmonary nodules.
    Hong Z; Cui B; Bai X; Li H; Cheng T; Sheng Y; Lu Y; Wu X; Jin D; Zhao J; Gou Y
    World J Surg Oncol; 2023 Sep; 21(1):284. PubMed ID: 37689670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
    Sur D; Advani S; Braithwaite D
    Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
    Guo Z; Zhao C; Wang Z
    Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.